PLA2G7 and Stroke: LpPLA2 activity is also more strongly associated with lipid markers then mass [4] and, as we previously reported, baseline lipid panel components were not clearly associated with an increased stroke risk in this cohort [32], possibly because of temporal trends in use of statins and levels of lipids.